BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 3926902)

  • 1. A quantitative method for assessing the third complement factor (C3) attached to the surface of opsonized Pseudomonas aeruginosa: interrelationship between C3 fixation, phagocytosis and complement consumption.
    Engels W; Endert J; Van Boven CP
    J Immunol Methods; 1985 Jul; 81(1):43-53. PubMed ID: 3926902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitation of the third component of human complement attached to the surface of opsonized bacteria: opsonin-deficient sera and phagocytosis-resistant strains.
    Verbrugh HA; van Dijk WC; van Erne ME; Peters R; Peterson PK; Verhoef J
    Infect Immun; 1979 Dec; 26(3):808-14. PubMed ID: 393633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of lipopolysaccharide in opsonization and phagocytosis of Pseudomonas aeruginosa.
    Engels W; Endert J; Kamps MA; van Boven CP
    Infect Immun; 1985 Jul; 49(1):182-9. PubMed ID: 3924827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of complement in the opsonization of mucoid and non-mucoid strains of Pseudomonas aeruginosa.
    Baltimore RS; Shedd DG
    Pediatr Res; 1983 Dec; 17(12):952-8. PubMed ID: 6419197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opsonization and phagocytosis of mucoid and non-mucoid Pseudomonas aeruginosa strains.
    Meshulam T; Verbrugh HA; Verhoef J
    Eur J Clin Microbiol; 1982 Apr; 1(2):112-7. PubMed ID: 6816585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement-mediated phagocytosis of Pseudomonas aeruginosa.
    Peterson PK; Kim Y; Schmeling D; Lindemann M; Verhoef J; Quie PG
    J Lab Clin Med; 1978 Dec; 92(6):883-94. PubMed ID: 105067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opsonization of encapsulated Staphylococcus aureus: the role of specific antibody and complement.
    Verbrugh HA; Peterson PK; Nguyen BY; Sisson SP; Kim Y
    J Immunol; 1982 Oct; 129(4):1681-7. PubMed ID: 7108223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologic investigations of mucoid strains of Pseudomonas aeruginosa: comparison of susceptibility to opsonic antibody in mucoid and nonmucoid strains.
    Baltimore RS; Mitchell M
    J Infect Dis; 1980 Feb; 141(2):238-47. PubMed ID: 6444976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opsonization of bacteroides by the alternative complement pathway reconstructed from isolated plasma proteins.
    Bjornson AB; Magnafichi PI; Schreiber RD; Bjornson HS
    J Exp Med; 1987 Mar; 165(3):777-98. PubMed ID: 3819646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of C3 levels on yeast opsonization by normal and pathological sera: identification of a complement independent opsonin.
    Kerr MA; Falconer JS; Bashey A; Beck JS
    Clin Exp Immunol; 1983 Dec; 54(3):793-800. PubMed ID: 6652976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Escherichia coli K capsular antigens during complement activation, C3 fixation, and opsonization.
    Van Dijk WC; Verbrugh HA; van der Tol ME; Peters R; Verhoef J
    Infect Immun; 1979 Aug; 25(2):603-9. PubMed ID: 385502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dichotomy between opsonization and serum complement activation by encapsulated staphylococci.
    Peterson PK; Kim Y; Wilkinson BJ; Schmeling D; Michael AF; Quie PG
    Infect Immun; 1978 Jun; 20(3):770-5. PubMed ID: 352958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different serum requirements for opsonization of two serologically identical strains of Pseudomonas aeruginosa.
    Ogle CK; Ogle JD; Stinnett JD; Stace P; Alexander JW
    Immunol Commun; 1980; 9(7):677-91. PubMed ID: 6160089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Staphylococcus aureus opsonization mediated via the classical and alternative complement pathways. A kinetic study using MgEGTA chelated serum and human sera deficient in IgG and complement factors C1s and C2.
    Verbrugh HA; Van Dijk WC; Peters R; Van Der Tol ME; Peterson PK; Verhoef J
    Immunology; 1979 Mar; 36(3):391-7. PubMed ID: 108204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation and binding of opsonic fragments of C3 on encapsulated Cryptococcus neoformans by using an alternative complement pathway reconstituted from six isolated proteins.
    Kozel TR; Wilson MA; Pfrommer GS; Schlageter AM
    Infect Immun; 1989 Jul; 57(7):1922-7. PubMed ID: 2525113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clindamycin enhances opsonization of Staphylococcus aureus.
    Milatovic D; Braveny I; Verhoef J
    Antimicrob Agents Chemother; 1983 Sep; 24(3):413-7. PubMed ID: 6638997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudomonas aeruginosa Psl polysaccharide reduces neutrophil phagocytosis and the oxidative response by limiting complement-mediated opsonization.
    Mishra M; Byrd MS; Sergeant S; Azad AK; Parsek MR; McPhail L; Schlesinger LS; Wozniak DJ
    Cell Microbiol; 2012 Jan; 14(1):95-106. PubMed ID: 21951860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The alternative activation pathway and complement component C3 are critical for a protective immune response against Pseudomonas aeruginosa in a murine model of pneumonia.
    Mueller-Ortiz SL; Drouin SM; Wetsel RA
    Infect Immun; 2004 May; 72(5):2899-906. PubMed ID: 15102802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of antibody and complement in phagocytosis by rabbit alveolar macrophages.
    Murphey SA; Root RK; Schreiber AD
    J Infect Dis; 1979 Dec; 140(6):896-903. PubMed ID: 120385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
    Lagergård T; Frisk A; Purvèn M; Nilsson LA
    Microb Pathog; 1995 Jan; 18(1):37-51. PubMed ID: 7783597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.